Merck continuing study of cholesterol drug in new class
Merck & Co. said Friday that it will continue a huge patient study of an experimental cholesterol medicine, the last one standing in a once-promising class of drugs being developed to prevent heart attacks, after an independent ...
Nov 13, 2015
0
21